Genetronics Announces Name Change To Inovio Biomedical Corporation

Genetronics Biomedical Corporation (AMEX: GEB), which is developing oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has changed its corporate name to Inovio Biomedical Corporation by filing a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware on March 31, 2005. Effective April 4, 2005, Genetronics' American Stock Exchange ticker symbol will change from "GEB" to "INO."

"This name change symbolizes the completion of the transformation of our management, financial position, and commercialization strategy," said Avtar Dhillon, MD, president and chief executive officer. "Inovio is well positioned for growth as we progress on our clinical development and advance toward commercialization."

Holders of stock certificates bearing the name "Genetronics Biomedical Corporation" may continue to hold them and will not be required to exchange them for new certificates or take any other action. The CUSIP number for the company's common stock will change to 45773H 10 2. Genetronics' wholly-owned subsidiary, Genetronics, Inc., intends to change its corporate name to Inovio, Inc. in the near future.